https://www.selleckchem.com/products/bi-2852.html
The conventional method of implanting balloon-expandable SAPIEN-3 (S3) valve results in a final 7030 or 8020 ratio of the valve in the aortaleft ventricular outflow tract with published rates of permanent pacemaker around 10%. We sought to evaluate whether higher implantation of S3 reduces conduction abnormalities including the need for permanent pacemaker. We included consecutive patients who underwent transfemoral transcatheter aortic valve replacement using S3 between April 2015 and December 2018 and compared outcomes with typical va
Like
Comment
Share
